IC

Ikarian Capital Portfolio holdings

AUM $773M
1-Year Est. Return 443.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+443.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$547M
AUM Growth
+$188M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
209
New
Increased
Reduced
Closed

Top Buys

1
+$15.3M
2
+$14.4M
3
+$14M
4
BMY icon
Bristol-Myers Squibb
BMY
+$11.6M
5
PCVX icon
Vaxcyte
PCVX
+$9.67M

Top Sells

1
+$15.3M
2
+$7.86M
3
+$7.57M
4
RPTX
Repare Therapeutics
RPTX
+$5.86M
5
ATRA icon
Atara Biotherapeutics
ATRA
+$5.53M

Sector Composition

1 Healthcare 98.96%
2 Industrials 0.18%
3 Financials 0%
4 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$31.8M 5.81%
135,842
+27,715
2
$23.9M 4.37%
1,364,990
-104,740
3
$20.2M 3.69%
1,063,961
-171,510
4
$17.9M 3.27%
288,400
+188,400
5
$17.3M 3.17%
+516,763
6
$15.7M 2.87%
649,542
-72,901
7
$14.5M 2.65%
+87,090
8
$14.3M 2.6%
+1,186,700
9
$14.2M 2.59%
684,573
-1,031,720
10
$13.4M 2.44%
61,536
+12,736
11
$12.9M 2.36%
+78,750
12
$12.3M 2.25%
1,836,545
+93,000
13
$11.3M 2.06%
26,934
+14,846
14
$10.9M 1.99%
235,587
-86,300
15
$10.1M 1.85%
1,048,383
+465,889
16
$9.42M 1.72%
293,941
-65,000
17
$9.41M 1.72%
+536,921
18
$9.29M 1.7%
16,307
+8,548
19
$8.93M 1.63%
280,989
+40,000
20
$8.7M 1.59%
+149,532
21
$7.76M 1.42%
1,466,147
-15,000
22
$7.48M 1.37%
1,155,436
-375,000
23
$7.34M 1.34%
276,110
+260,000
24
$7.07M 1.29%
150,000
25
$6.88M 1.26%
638,094
1
2 3 4 5